| Financial Year |
March 31 2023 |
| Monetary Funds |
208,698,379.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
19,277,410.00 |
| Advances to Suppliers |
42,354,589.51 |
| Other Receivables |
20,541,702.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
186,808,616.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,979,816.96 |
| Total Current Assets |
480,660,515.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
242,535.67 |
| Investment Properties |
-- |
| Fixed Assetes |
763,127,919.62 |
| Under-construction Projects |
48,262,460.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,147,649.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,550,970.97 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
6,362,195.64 |
| Sub-Total of Non-Current Assets |
970,163,445.17 |
| Total Assets |
1,450,823,960.64 |
| Short-Term Loans |
242,301,225.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
164,544,878.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,787,207.69 |
| Taxes Payable |
4,508,780.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,389,157.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,317,522.37 |
| Other Current Liabilities |
785,295.69 |
| Sub-Total of Current Liabilities |
506,724,379.13 |
| Long-term Loans |
120,077,700.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
221,495,675.02 |
| Total Liabilities |
728,220,054.15 |
| Paid-In Capital(Or Share Stock) |
153,500,000.00 |
| Capital Surplus |
307,188,750.94 |
| Surplus Reserve |
33,825,750.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
228,338,521.58 |
| Minority Stockholder's Interest |
-249,116.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
722,853,023.18 |
| Owner's Equity（Stockholder's Equity） |
722,603,906.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,450,823,960.64 |
